HRP20080108T3 - Farmaceutski pripravci zasnovani na solima idazoksana ili na jednom od njegovih polimorfa - Google Patents

Farmaceutski pripravci zasnovani na solima idazoksana ili na jednom od njegovih polimorfa

Info

Publication number
HRP20080108T3
HRP20080108T3 HR20080108T HRP20080108T HRP20080108T3 HR P20080108 T3 HRP20080108 T3 HR P20080108T3 HR 20080108 T HR20080108 T HR 20080108T HR P20080108 T HRP20080108 T HR P20080108T HR P20080108 T3 HRP20080108 T3 HR P20080108T3
Authority
HR
Croatia
Prior art keywords
idasoxane
polymorphs
salts
pharmaceutical preparations
preparations based
Prior art date
Application number
HR20080108T
Other languages
English (en)
Croatian (hr)
Inventor
Bougaret Joel
Avan Jean-Louis
Segonds Roland
Original Assignee
Pierre Fabre Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pierre Fabre Medicament filed Critical Pierre Fabre Medicament
Publication of HRP20080108T3 publication Critical patent/HRP20080108T3/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Psychiatry (AREA)
  • Inorganic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
HR20080108T 2003-10-28 2004-10-28 Farmaceutski pripravci zasnovani na solima idazoksana ili na jednom od njegovih polimorfa HRP20080108T3 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0312626A FR2861299B1 (fr) 2003-10-28 2003-10-28 Compositions pharmaceutiques a base de derives d'idasoxan sous formes polymorphes
PCT/FR2004/002773 WO2005041956A1 (fr) 2003-10-28 2004-10-28 Compositions pharmaceutiques a base de sel d’idazoxan ou l’un de ses polymorphes

Publications (1)

Publication Number Publication Date
HRP20080108T3 true HRP20080108T3 (hr) 2008-04-30

Family

ID=34400871

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20080108T HRP20080108T3 (hr) 2003-10-28 2004-10-28 Farmaceutski pripravci zasnovani na solima idazoksana ili na jednom od njegovih polimorfa

Country Status (18)

Country Link
US (2) US7338970B2 (de)
EP (1) EP1682124B1 (de)
JP (1) JP5160090B2 (de)
CN (2) CN102349873B (de)
AT (1) ATE381331T1 (de)
AU (1) AU2004285316B2 (de)
BR (1) BRPI0416006B1 (de)
CA (1) CA2542752A1 (de)
CY (1) CY1107304T1 (de)
DE (1) DE602004010837T2 (de)
DK (1) DK1682124T3 (de)
ES (1) ES2297525T3 (de)
FR (1) FR2861299B1 (de)
HR (1) HRP20080108T3 (de)
MX (1) MXPA06004717A (de)
PL (1) PL1682124T3 (de)
PT (1) PT1682124E (de)
WO (1) WO2005041956A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8476307B2 (en) * 2003-10-28 2013-07-02 Pierre Fabre Medicament Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof
US8088824B2 (en) * 2007-08-15 2012-01-03 Reata Pharmaceuticals Inc. Forms of CDDO methyl ester
UA102128C2 (en) * 2008-12-05 2013-06-10 Х. Луннбек А/С Nalmefene hydrochloride dihydrate
US12702790B2 (en) 2019-06-13 2026-08-11 Hollister Incorporated Reusable urinary catheter kits
LT3952973T (lt) 2019-06-13 2023-07-10 Hollister Incorporated Daugkartinio naudojimo šlapimo kateterio produktai
WO2020263859A1 (en) 2019-06-25 2020-12-30 Hollister Incorporated Reusable urinary catheter products
EP4479365A4 (de) * 2022-02-16 2026-03-11 Terran Biosciences Inc Deuteriertes idazoxan und verfahren zur verwendung davon
CN117338772B (zh) * 2023-11-22 2024-04-09 徐州医科大学 一种药物组合物及其在制备用于预防和/或治疗重性抑郁障碍的药物中的应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PH16249A (en) * 1980-02-04 1983-08-16 Reckitt & Colmann Prod Ltd Imidazoline derivatives,its pharmaceutical composition and method of use
US4541893A (en) * 1984-05-15 1985-09-17 Advanced Micro Devices, Inc. Process for fabricating pedestal interconnections between conductive layers in an integrated circuit
FR2698789B1 (fr) 1992-12-07 1995-03-03 Pf Medicament Utilisation de l'idazoxan et ses dérivés pour la préparation d'un médicament destiné au traitement de la maladie de Parkinson et de son évolution.
US5492907A (en) * 1992-12-09 1996-02-20 The United States Of America As Represented By The Department Of Health & Human Services Antipsychotic composition and method of treatment
IT1264517B1 (it) * 1993-05-31 1996-09-24 Ekita Investments Nv Compressa farmaceutica atta al rilascio in tempi successivi dei principi attivi in essa veicolati
US5574059A (en) * 1995-10-27 1996-11-12 Cornell Research Foundation, Inc. Treating disorders mediated by vascular smooth muscle cell proliferation
FR2746314B1 (fr) 1996-03-25 1998-06-12 Pf Medicament Produit contenant du milnacipran et de l'idazoxan comme preparation pharmaceutique combinee
US6232215B1 (en) * 1996-09-18 2001-05-15 United Microelectronics Corp. Method for forming increased density for interconnection metallization
FR2774811B1 (fr) * 1998-02-10 2003-05-09 Sgs Thomson Microelectronics Procede de formation de lignes conductrices sur des circuits integres
FR2801786B1 (fr) * 1999-12-01 2002-03-01 Fabre Pierre Cosmetique Nouvelles compositions topiques a base d'idazoxan et de cafeine ou de ses derives solubles et leur utilisation comme amincissant et/ou dans le traitement de la cellulite

Also Published As

Publication number Publication date
PL1682124T3 (pl) 2008-05-30
MXPA06004717A (es) 2006-07-05
US7338970B2 (en) 2008-03-04
CA2542752A1 (fr) 2005-05-12
PT1682124E (pt) 2008-03-05
DE602004010837D1 (de) 2008-01-31
EP1682124A1 (de) 2006-07-26
US8124640B2 (en) 2012-02-28
DK1682124T3 (da) 2008-04-28
CY1107304T1 (el) 2012-11-21
FR2861299A1 (fr) 2005-04-29
US20080113022A1 (en) 2008-05-15
FR2861299B1 (fr) 2006-01-27
US20050090537A1 (en) 2005-04-28
CN102349873A (zh) 2012-02-15
CN1870993B (zh) 2012-04-04
CN1870993A (zh) 2006-11-29
EP1682124B1 (de) 2007-12-19
CN102349873B (zh) 2013-09-25
JP2007509911A (ja) 2007-04-19
DE602004010837T2 (de) 2008-12-11
ES2297525T3 (es) 2008-05-01
AU2004285316A1 (en) 2005-05-12
JP5160090B2 (ja) 2013-03-13
HK1094769A1 (en) 2007-04-13
ATE381331T1 (de) 2008-01-15
AU2004285316B2 (en) 2010-08-19
WO2005041956A1 (fr) 2005-05-12
BRPI0416006B1 (pt) 2019-02-05
BRPI0416006A (pt) 2007-01-02

Similar Documents

Publication Publication Date Title
HRP20020198B1 (hr) Formulacija moksifloksacina i kuhinjske soli
HRP20010332B1 (hr) Farmaceutski pripravak moksifloksacina
EP1442016A4 (de) 1h-indolderivate als hochselektive cyclooxygenase-2-inhibitoren
DK1114032T3 (da) 4-aminosubstituerede-2-substituerede-1,2,3,4-tetrahydroquinoliner som CETB-inhibitorer
MA27230A1 (fr) Derives d'aminoindazoles comme inhibiteurs de proteines-kinase
NO20006323D0 (no) Glykopeptidderivater og farmasöytiske sammensetninger som inneholder disse
NO20044603L (no) Hydraulisk aktuator
EE200300054A (et) Kinaasi inhibiitoritena toimivad bitsüklopürasoolid, nende valmistamismeetod, kasutamine ja neid sisaldavad farmatseutilised kompositsioonid
EA200100678A1 (ru) N-уреидоалкил-пиперидины в качестве модуляторов активности рецепторов хемокинов
GEP20084461B (en) New derivative of 3,3- diphenyl-propylamine
EE05081B1 (et) Farmatseutilised kompositsioonid, mis sisaldavad 3-aminoasetidiini derivaate, 3-aminoasetidiini derivaadid ja nende valmistamise meetodid
EP1539122A4 (de) Pharmazeutische wässrige 2,6-diisopropylphenol-zusammensetzungen
HN2001000281A (es) Nuevas imidazotriazinonas sustituidas
BR0209242A (pt) Aminopolidiorganossiloxanos amido-funcionais
HRP20090113T3 (hr) C-aril glukozid sglt2 inhibitori i postupak za njihovu proizvodnju
HRP20050625A2 (hr) Tablete bupropion hidroklorida s promijenjenim otpuštanjem
BR0109703A (pt) Derivados de piperazina
BR0114903A (pt) 7-azaindóis, sua aplicação como inibidores da fosfodiesterase 4 e processos para a sua preparação
MEP15908A (en) 1-amino-2-oxy-substituted tetrahydronaphtalene derivatives, methods for the production thereof, and their use as antiphlogistics
BR0109542A (pt) Derivados de imidazopirina alquilados
BR9910539A (pt) Derivados de 2 - (2 - clorofenil) - 3,4 - dihidro - 2h - pirrol
NO20040860L (no) Farmasoytisk sammensetning som innbefatter lumiracoxib
ATE398109T1 (de) 4-pyrimidinamine derivate, pharmazeutische zusammenstellungen und verwandte methoden
BR0114380A (pt) Derivados-1-aminobutan-3-ol-substituìdos
BR0103048A (pt) Derivados de n-triazolilmetil-piperazina como antagonistas de receptores de neuroquinina